The Effect of Low Doses of Memantine on Serum Levels of Inflammatory Mediators in Methadone-Dependent Rats

Document Type : Original Article (s)

Authors

1 Student Medicine, Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

2 Associate Professor, Medical Toxicology and Drug Abuse Research Center (MTDRC) AND Department of Physiology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

3 Associate Professor, Medical Toxicology and Drug Abuse Research Center (MTDRC) AND Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

4 Associate Professor, Social Determinants of Health Research Center AND Department of Health Education and Promotion, School of Health, Birjand University of Medical Sciences, Birjand, Iran

Abstract

Background: Opioid abuse is a major and challenging public health problem with a broad range of physical, mental, and psychiatric consequences worldwide. This study was designed to evaluate the effect of low doses of memantine on serum levels of inflammatory mediators in methadone-dependent rats.Methods: This study was performed on 40 male wistar rats weighing 300-350 grams in four groups (n = 10). The rats were weighed at the beginning and the end of the study, and fasting blood glucose was measured by glucometer. Within 10 days, one group received intraperitoneal methadone 5 mg/kg, two groups received memantine 30 minutes before methadone injection subcutaneously 1 and 2 mg/kg, respectively, and the last group received normal saline. At the end, rats were sacrificed, and serum levels of high-sensitivity C-reactive protein (hsCRP), nuclear factor kappa B (NF-kB), tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and lipid profiles were measured.Findings: Thera was a significant difference between the four groups in the mean level of NFκβ (P = 0.040) and hsCPR (P = 0.020). There was a significant difference between lipid profiles in mean levels of low-density lipoprotein (LDL) (P < 0.001), high-density lipoprotein (HDL) (P = 0.040), and triglyceride (P = 0.030).Conclusion: Our results showed that dependence on methadone affects the level of inflammatory mediators, and memantine could reduce these levels. Therefore, memantine can be considered as a new anti-addiction approach in the treatment of opioid-dependent patients who are on methadone maintenance treatment (MMT).

Keywords

References

  1. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J 2012; 9: 18.
  2. World Health Organization. Management of substance abuse: Forum on alcohol, drugs and addictive behaviour [Online]. [cited 2017 Jun 6]; Available from: URL: https://www.who.int/substance_abuse/en/
  3. Shamsalinia A, Norouzi K, Fallahi-Khoshknab M, Farhoudian A, Ghaffari F. Experiences of substance abusers from methadone maintenance therapy. Med J Islam Repub Iran 2017; 31: 45.
  4. Mokri A, Norouzi A. Protocol on management of opioid dependence with methadone. 3rd ed. Tehran, Iran: The Office for Prevention and Treatment of Substance Abuse, Psycho-Social Health and Addiction Office; 2014. [In Persian].
  5. Mokri A, Schottenfeld R. Drug abuse and HIV transmission in Iranresponding to the public health challenges. In: Celentano DD, Beyrer C, editors. Public health aspects of HIV/AIDS in low and middle income countries: Epidemiology, prevention and care. New York, NY: Springer; 2009. p. 583-99.
  6. Chan YY, Yang SN, Lin JC, Chang JL, Lin JG, Lo WY. Inflammatory response in heroin addicts undergoing methadone maintenance treatment. Psychiatry Res 2015; 226(1): 230-4.
  7. Ministry of Health and Medical Education. Statistics of methadone production. Tehran, Iran: Ministry of Health and Medical Education; 2013. [In Persian].
  8. Sacerdote P. Opioids and the immune system. Palliat Med 2006; 20(Suppl 1): S9-15.
  9. Blanco-Gandia M, Montagud-Romero S, Rodriguez-Arias M. Present and future pharmacological treatments for opioid addiction. In: Morphine. IntechOpen; 2019.
  10. Chang YH, Chen SL, Lee SY, Chen PS, Wang TY, Lee IH, et al. Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy. Sci Rep 2015; 5: 9708.
  11. Meijerink H, Indrati A, Utami F, Soedarmo S, Alisjahbana B, Netea MG, et al. Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individuals. PLoS One 2015; 10(4): e0122822.
  12. Babic S, Ondrejcakova M, Bakos J, Racekova E, Jezova D. Cell proliferation in the hippocampus and in the heart is modified by exposure to repeated stress and treatment with memantine. J Psychiatr Res 2012; 46(4): 526-32.
  13. Chen SL, Tao PL, Chu CH, Chen SH, Wu HE, Tseng LF, et al. Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol 2012; 7(2): 444-53.
  14. Pacesova D, Novotny J, Bendova Z. The effect of chronic morphine or methadone exposure and withdrawal on clock gene expression in the rat suprachiasmatic nucleus and AA-NAT activity in the pineal gland. Physiol Res 2016; 65(3): 517-25.
  15. Pierce TL, Hope W, Raper C. The induction and quantitation of methadone dependence in the rat. J Pharmacol Toxicol Methods 1996; 36(3): 137-46.
  16. Angelucci F, Ricci V, Pomponi M, Conte G, Mathe AA, Attilio TP, et al. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 2007; 21(8): 820-5.
  17. Ghazavi A, Mosayebi G, Solhi H, Rafiei M, Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunol Lett 2013; 153(1-2): 22-6.
  18. Ahmed AS, Elgharabawy RM, Al-Najjar AH. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease. Exp Biol Med (Maywood) 2017; 242(13): 1335-44.
  19. Chang HH, Chen PS, Wang TY, Lee SY, Chen SL, Huang SY, et al. Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder. J Affect Disord 2017; 221: 151-7.
  20. Nennig SE, Schank JR. The Role of NFkB in Drug Addiction: Beyond Inflammation. Alcohol Alcohol 2017; 52(2): 172-9.
  21. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, et al. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 2009; 29(11): 3529-37.
  22. Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, et al. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 2008; 579(1-3): 160-6.
  23. Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, et al. Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial. Sci Rep 2015; 5: 10140.
  24. Lee SY, Chen SL, Chang YH, Chen PS, Huang SY, Tzeng NS, et al. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. J Psychiatr Res 2013; 47(10): 1343-8.
  25. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, et al. The association between adiponectin and diabetes in the Korean population. Metabolism 2008; 57(6): 853-7.
  26. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68(11): 975-81.
  27. Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 1999; 274(7): 4140-6.
  28. Hillard CJ. Lipids and drugs of abuse. Life Sci 2005; 77(14): 1531-42.
  29. Buydens-Branch, Branchey M. Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom Med 2003; 65(1): 86-91.
  30. Lin SH, Yang YK, Lee SY, Hsieh PC, Chen PS, Lu RB, et al. Association between cholesterol plasma levels and craving among heroin users. J Addict Med 2012; 6(4): 287-91.
Journal of Isfahan Medical School
Volume 37, Issue 523 - Serial Number 523
March and April 2019
Pages 392-399

Files

History

  • Receive Date: 01 May 2019
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics